W
William W. Zhao
Researcher at Pharmacia
Publications - 9
Citations - 4571
William W. Zhao is an academic researcher from Pharmacia. The author has contributed to research in topics: Placebo & Celecoxib. The author has an hindex of 9, co-authored 9 publications receiving 4466 citations.
Papers
More filters
Journal ArticleDOI
Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid Arthritis: The CLASS Study: A Randomized Controlled Trial
Fred E. Silverstein,Gerald A. Faich,Jay L. Goldstein,Lee S. Simon,Theodore Pincus,Andrew Whelton,Robert W. Makuch,Glenn M. Eisen,Naurang M. Agrawal,William F. Stenson,Aimee M. Burr,William W. Zhao,Jeffrey D. Kent,James B. Lefkowith,Kenneth M. Verburg,G. Steven Geis +15 more
TL;DR: In this study, celecoxib, at dosages greater than those indicated clinically, was associated with a lower incidence of symptomatic ulcers and ulcer complications combined, as well as other clinically important toxic effects, compared with NSAIDs at standard dosages.
Journal ArticleDOI
Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis : A randomized controlled trial
Lee S. Simon,Arthur L. Weaver,David Y. Graham,A J Kivitz,Peter E. Lipsky,Richard C. Hubbard,Peter C. Isakson,Kenneth M. Verburg,Shawn S. Yu,William W. Zhao,G S Geis +10 more
TL;DR: All dosages of celecoxib were efficacious in the treatment of rheumatoid arthritis and did not affect COX-1 activity in the GI tract mucosa as evidenced by less frequent incidence of endoscopic ulcers compared with naproxen.
Journal ArticleDOI
Efficacy and tolerability of celecoxib versus hydrocodone/acetaminophen in the treatment of pain after ambulatory orthopedic surgery in adults.
TL;DR: Over 8 hours, patients with moderate to severe pain after orthopedic surgery experienced comparable analgesia with single doses of celecoxib and hydrocodone/acetaminophen and had superior scores on a modified American Pain Society Patient Outcome Questionnaire.
Journal Article
Randomized placebo-controlled trial comparing efficacy and safety of valdecoxib with naproxen in patients with osteoarthritis.
TL;DR: Valdecoxib (10 and 20 mg once daily) is significantly superior to placebo and as effective as naproxen (500 mg twice daily) in improving moderate to severe osteoarthritis of the knee.
Journal ArticleDOI
Incidence of gastroduodenal ulcers associated with valdecoxib compared with that of ibuprofen and diclofenac in patients with osteoarthritis.
David H Sikes,Naurang M. Agrawal,William W. Zhao,Jeffrey D. Kent,David P. Recker,Kenneth M. Verburg +5 more
TL;DR: The data indicate that administration of valdecoxib offers similar efficacy for the treatment of osteoarthritis but improved upper-gastrointestinal safety compared with the conventional NSAIDs, ibuprofen and diclofenac, based on the significantly lower incidence of gastroduodenal ulcers detected by endoscopy.